AI assistant
Sending…
Bioventus Inc. — Director's Dealing 2021
Apr 5, 2021
32934_dirs_2021-04-05_6b094cea-f56d-452a-bdb3-94020cabec1e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-02-21
Reporting Person: CHURCH KATRINA J (SVP & Chief Compliance Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-11 | Common Stock | P | 2500 | $13.00 | Acquired | 2500 | Direct |
More from Bioventus Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17